Breast Cancer Test Rates Drug Therapy Candidates (HealthDay)
Breast Cancer Test Rates Drug Therapy Candidates (HealthDay)
HealthDay - TUESDAY, July 8 (HealthDay News) — The U.S. Food and Drug Administration has approved a genetic test designed to evaluate whether a person with breast cancer is a good candidate for treatment with the drug Herceptin (trastuzumab).
FDA OKs Invitrogen genetic test for breast cancer (Reuters)
Reuters - The U.S. Food and Drug Administration on Tuesday approved Invitrogen Corp’s genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin.
Elevated Blood Levels Of A Protein Are Linked To Asbestos-induced Cancers
Researchers at New York University School of Medicine and Wayne State University have found a molecule that reveals the early stages of pleural mesothelioma, a chest cancer caused by asbestos. The finding opens the way to a blood test for the disease, according to a new study published in the Oct. 13 issue of The New England Journal of Medicine.
Molecule Uses Cellular Recycling to Treat Kidney Cancer (HealthDay)
HealthDay - MONDAY, July 7 (HealthDay News) — A molecule that uses a cellular recycling process called autophagy to kill cancer cells has been identified by Stanford University researchers.
Cancer death rate drop tied to education levels (Reuters)
Reuters - Declines in death rates from the four leading types of cancer in the United States since the early 1990s have been driven largely by progress among college-educated men and women, researchers said on Tuesday.
Tags: cancer cells, peritoneal, mesothelium, abdominal cavity, illinois mesothelioma lawyer, asbestos fibers, respiratory disease, attorneys, Mesothelioma Asbestos, risk factors
